Intuitive Surgical (NASDAQ:ISRG) Trading Down 0.6% After Insider Selling

Intuitive Surgical, Inc. (NASDAQ:ISRG)’s share price traded down 0.6% on Tuesday following insider selling activity. The company traded as low as $589.00 and last traded at $592.23. 187,308 shares were traded during mid-day trading, a decline of 90% from the average session volume of 1,792,521 shares. The stock had previously closed at $595.70.

Specifically, EVP Myriam Curet sold 408 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now directly owns 3,282 shares of the company’s stock, valued at $1,936,380. The trade was a 7.58 % decrease in their position. The disclosure for this sale can be found here.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent analyst reports. Robert W. Baird boosted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. BTIG Research increased their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Citigroup boosted their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Trading Down 0.7 %

The stock has a market capitalization of $210.73 billion, a PE ratio of 92.30, a PEG ratio of 5.67 and a beta of 1.39. The firm’s 50-day simple moving average is $555.91 and its two-hundred day simple moving average is $515.92.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently bought and sold shares of ISRG. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical during the fourth quarter valued at $449,000. Seilern Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $82,517,000. Sycomore Asset Management raised its position in Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Exome Asset Management LLC lifted its stake in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. grew its position in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.